Skip to Main Content

Medicaid Formulary Updates Effective 08/1/2025

Date: 07/01/25

Effective August 1, 2025, Arizona Complete Health-Complete Care Plan (AZCH-CCP) will implement AHCCCS formulary changes based on the recommendations from the May 20, 2025, AHCCCS Pharmacy and Therapeutics (P&T) Committee Meeting.

To review the AzCH-CCP Preferred Drug Lists (PDLs) including the recent updates, visit our website at: www.azcompletehealth.comExternal Link > For Providers > Pharmacy > Preferred Drug Lists.

We encourage prescribing clinicians to review our PDLs for preferred formulary alternatives prior to prescribing. The table below highlights some of the upcoming formulary changes. Additionally, there is no exception allowed for current preferred products moving to a non-preferred status.

Drug Class

Drug Name

Preferred Biosimilar Label Name

Preferred Biosimilar Chemical Name

Preferred Biosimilar Manufacturer

Products Moving to Non-Preferred Status

Eylea

Aflibercept

Pavblu

Afilbercept-ayyh

Amgen

New Addition

Humira

Adalimumab

Unbranded Version
Hadlima

Adalimumab-fjkp
Adalimumab-bwwd

Biocon Biologics
Organon

Simlandi
Adalimumab-abdm

Avastin

Bevacizumab

Mvasi
Zirabev

Bevacizumab-awwb
Bevacizumab-bvzr

Amgen
Pfizer

No Changes

Soliris

Eculizumab

Epysqli

Eculizumab-aagh

Teva

New Addition

Neupogen

Filgrastim

Releuko
Nivestym

Filgastrim-ayow
Filgrastim-aafi

Amneal
Pfizer

Neupogen

Neulasta

Pegfilgrastim

Fulphila
Fylnetra

Pegfilgrastim-jmdb
Pegfilgrastim-pbbk

Mylan
Amneal

Undenyca
Nyvepria
Ziextenzo

Lucentis

Ranibizumab

Cimerli

Ranibizumab-eqrun

Sandoz

New Addition

Rituxan

Rituximab

Riabni
Ruxience

Rituximab-arrx
Rituximab-pvvr

Amgen
Pfizer

Truxima

Actemra

Tocilizumab

Tyenne

Tocilizumab-aazg

Fresenius

New Addition

Herceptin

Trastuzumab

Ogivri

Trastuzumab-dkst

Mylan-Biocon Biologics

Kanjinti, Herzuma, Trazimera

Stelara

Ustekinumab

Yesintek

Ustekinumab-kfce

Biocon Biologics

New Addition

 

*AHCCCS P&T determines whether to permit continued use of a non-formulary medication. If it is not permitted, members must switch to the preferred formulary alternative, and a new prescription may be required. (See AHCCCS Policy 310-V).

If you have questions, please contact our Pharmacy Provider Liaison at azch_pharmacyproviderliaison@azcompletehealth.com or 1-888-788-4408 ext. 6031278